trastuzumab
Drug Name | Form | Strength | ARHS | Blue Ridge | Caldwell | Chatham | Johnston | Lenoir | Medical Center | Nash | Pardee | Rex | Rockingham | Southeastern | Wayne | Youth Behavioral Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trastuzumab (Herceptin) | POWDER FOR INJECTION, INTRAVENOUS | 150 mg | ||||||||||||||
Trastuzumab-dkst (Ogivri) | POWDER FOR INJECTION, INTRAVENOUS | 150 mg | ||||||||||||||
Trastuzumab-qyyp (Trazimera) | POWDER FOR INJECTION, INTRAVENOUS | 150 mg | ||||||||||||||
Trastuzumab-dkst (Ogivri) | POWDER FOR INJECTION, INTRAVENOUS | 420 mg | ||||||||||||||
Trastuzumab-qyyp (Trazimera) | POWDER FOR INJECTION, INTRAVENOUS | 420 mg |
UNC Health
System Formulary Restriction:
Use of Ogivri injection is restricted to outpatient encounters or clinic use only (ie, no inpatient use)
Use of Trazimera injection is restricted to patients in outpatient or clinic encounters (ie, no inpatient use) who meet one of the following criteria:
Use of Herceptin injection is restricted to patients in outpatient or clinic encounters (ie, no inpatient use) who meet one of the following criteria:
Med Center
UNC Medical Center Formulary Restrictions
Rex
Rex Hematology-Oncology Formulary Restrictions